AP2014008171A0 - Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same - Google Patents

Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same

Info

Publication number: AP2014008171A0
Authority: AP; ARIPO
Prior art keywords: producing; pharmaceutical composition; same; medicinal agent; improved flowability
Prior art date: 2012-07-11

Application number

AP2014008171A

Other languages

English (en)

Inventor

Alexandre Viktorovich Demin

Alexandre Vasilievich Ivachtchenko

Original Assignee

Alla Chem Llc

Alexandre Vasilievich Ivachtchenko

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-07-11

Filing date

2013-07-05

Publication date

2014-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49446598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014008171(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-07-05 Application filed by Alla Chem Llc, Alexandre Vasilievich Ivachtchenko filed Critical Alla Chem Llc

2014-12-31 Publication of AP2014008171A0 publication Critical patent/AP2014008171A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
- A61J3/074—Filling capsules; Related operations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Virology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Transplantation (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

AP2014008171A 2012-07-11 2013-07-05 Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same AP2014008171A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
RU2012129101/15A RU2496486C1 (ru)	2012-07-11	2012-07-11	Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение
PCT/RU2013/000572 WO2014011083A2 (ru)	2012-07-11	2013-07-05	Фармацевтическая композиция с улучшенной сыпучестью, лекарственное средство, способ получения и применение

Publications (1)

Publication Number	Publication Date
AP2014008171A0 true AP2014008171A0 (en)	2014-12-31

Family

ID=49446598

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2014008171A AP2014008171A0 (en)	2012-07-11	2013-07-05	Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same

Country Status (22)

Country	Link
US (1)	US9370576B2 (xx)
EP (1)	EP2873416B1 (xx)
JP (1)	JP6093015B2 (xx)
KR (1)	KR20150036228A (xx)
CN (1)	CN104487063B (xx)
AP (1)	AP2014008171A0 (xx)
BR (1)	BR112015000544A2 (xx)
CL (1)	CL2015000052A1 (xx)
CO (1)	CO7310521A2 (xx)
EA (1)	EA027712B1 (xx)
GE (1)	GEP201606571B (xx)
IL (1)	IL236562A0 (xx)
IN (1)	IN2015DN00130A (xx)
MA (1)	MA37693B1 (xx)
MX (1)	MX2015000467A (xx)
PE (1)	PE20150632A1 (xx)
RU (1)	RU2496486C1 (xx)
SG (1)	SG11201500178QA (xx)
TN (1)	TN2015000006A1 (xx)
UA (1)	UA113216C2 (xx)
WO (1)	WO2014011083A2 (xx)
ZA (1)	ZA201409481B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014110398A1 (en)	2013-01-10	2014-07-17	Edh Us Llc	Ball spin rate measurement
RU2611415C1 (ru) *	2015-11-17	2017-02-21	Общество С Ограниченной Ответственностью "Валента - Интеллект"	ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ ТЕРАПЕВТИЧЕСКИМ ЭФФЕКТОМ В ОТНОШЕНИИ ДЕМИЕЛИНИЗИРУЮЩИХ ЗАБОЛЕВАНИЙ (Варианты)
EP3813822A4 (en) *	2018-06-27	2022-03-16	Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi	SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION COMPRISING TERIFLUNOMIDE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5604229A (en)	1992-10-21	1997-02-18	Yoshitomi Pharmaceutical Industries, Ltd.	2-amino-1,3-propanediol compound and immunosuppressant
SI0812588T1 (en)	1995-12-28	2005-02-28	Mitsubishi Pharma Corporation	Pharmaceutical external preparations for topical administration comprising 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol for the treatment of diseases induced from immune disorder
US6476004B1 (en)	1996-07-18	2002-11-05	Mitsubishi Pharma Corporation	Pharmaceutical composition
GB9624038D0 (en)	1996-11-19	1997-01-08	Sandoz Ltd	Organic compounds
JPH1180026A (ja)	1997-09-02	1999-03-23	Yoshitomi Pharmaceut Ind Ltd	新規免疫抑制剤、その使用方法およびその同定方法
JP4627356B2 (ja) *	1999-06-30	2011-02-09	昭松森	ウイルス性心筋炎の予防または治療薬剤
JP2002316985A (ja)	2001-04-20	2002-10-31	Sankyo Co Ltd	ベンゾチオフェン誘導体
RU2358717C2 (ru)	2002-05-16	2009-06-20	Новартис Аг	Применение средств, связывающих edg-рецептор, в лечении ракового заболевания
AR043987A1 (es) *	2003-04-08	2005-08-17	Novartis Ag	Composiciones farmaceuticas para administracion oral de agonistas del receptor de fosfato de esfingosina-1
WO2005025553A2 (en) *	2003-09-12	2005-03-24	Neuronova Ab	Treatment of disorders of nervous systemsystem with fty720
MX2007001236A (es)	2004-07-30	2007-03-23	Novartis Ag	Formulaciones de compuestos de 2-amino-1, 3-propanodiol.
GT200600350A (es)	2005-08-09	2007-03-28		Formulaciones líquidas
MXPA05008573A (es)	2005-08-12	2007-02-12	Leopoldo Espinosa Abdala	Composicion de isoflavonas para tratamiento de los sintomas y trastornos fisiologicos de la menopausia.
BRPI0717570B8 (pt) *	2006-09-26	2021-05-25	Novartis Ag	composição farmacêutica sólida adequada para administração oral, seu uso e seu processo de produção
EP1923058A1 (en) *	2006-09-26	2008-05-21	Novartis AG	Coated pharmaceutical composition comprising an S1P agonist or modulator
MY159358A (en) *	2007-10-12	2016-12-30	Novartis Ag	Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
CA2797042A1 (en) *	2010-04-22	2011-10-27	Ratiopharm Gmbh	Fingolimod in the form of a solid solution
WO2011131370A1 (en) *	2010-04-22	2011-10-27	Ratiopharm Gmbh	Melt-granulated fingolimod

2012
- 2012-07-11 RU RU2012129101/15A patent/RU2496486C1/ru active
2013
- 2013-05-07 UA UAA201500892A patent/UA113216C2/uk unknown
- 2013-07-05 WO PCT/RU2013/000572 patent/WO2014011083A2/ru not_active Ceased
- 2013-07-05 EA EA201500096A patent/EA027712B1/ru not_active IP Right Cessation
- 2013-07-05 SG SG11201500178QA patent/SG11201500178QA/en unknown
- 2013-07-05 EP EP13817392.7A patent/EP2873416B1/en not_active Not-in-force
- 2013-07-05 CN CN201380036592.6A patent/CN104487063B/zh not_active Expired - Fee Related
- 2013-07-05 BR BR112015000544A patent/BR112015000544A2/pt active Search and Examination
- 2013-07-05 AP AP2014008171A patent/AP2014008171A0/xx unknown
- 2013-07-05 PE PE2015000009A patent/PE20150632A1/es not_active Application Discontinuation
- 2013-07-05 MX MX2015000467A patent/MX2015000467A/es unknown
- 2013-07-05 GE GEAP201313729A patent/GEP201606571B/en unknown
- 2013-07-05 JP JP2015521577A patent/JP6093015B2/ja not_active Expired - Fee Related
- 2013-07-05 KR KR1020157002215A patent/KR20150036228A/ko not_active Ceased
- 2013-07-05 US US14/410,584 patent/US9370576B2/en not_active Expired - Fee Related
2014
- 2014-12-22 ZA ZA2014/09481A patent/ZA201409481B/en unknown
- 2014-12-24 MA MA37693A patent/MA37693B1/fr unknown
2015
- 2015-01-01 IL IL236562A patent/IL236562A0/en unknown
- 2015-01-06 IN IN130DEN2015 patent/IN2015DN00130A/en unknown
- 2015-01-07 TN TNP2015000006A patent/TN2015000006A1/fr unknown
- 2015-01-08 CL CL2015000052A patent/CL2015000052A1/es unknown
- 2015-01-08 CO CO15003855A patent/CO7310521A2/es unknown

Also Published As

Publication number	Publication date
ZA201409481B (en)	2016-02-24
GEP201606571B (en)	2016-11-10
CO7310521A2 (es)	2015-06-30
UA113216C2 (xx)	2016-12-26
EP2873416B1 (en)	2017-04-26
US20150335754A1 (en)	2015-11-26
MA37693B1 (fr)	2017-01-31
KR20150036228A (ko)	2015-04-07
US9370576B2 (en)	2016-06-21
CL2015000052A1 (es)	2015-09-04
CN104487063A (zh)	2015-04-01
JP6093015B2 (ja)	2017-03-08
EP2873416A4 (en)	2016-03-16
WO2014011083A3 (ru)	2014-03-06
IL236562A0 (en)	2015-02-26
WO2014011083A2 (ru)	2014-01-16
EP2873416A2 (en)	2015-05-20
TN2015000006A1 (en)	2016-06-29
MA37693A1 (fr)	2016-06-30
EA027712B1 (ru)	2017-08-31
EA201500096A1 (ru)	2015-05-29
CN104487063B (zh)	2017-05-10
JP2015522068A (ja)	2015-08-03
RU2496486C1 (ru)	2013-10-27
IN2015DN00130A (xx)	2015-05-29
MX2015000467A (es)	2015-06-05
BR112015000544A2 (pt)	2017-10-24
PE20150632A1 (es)	2015-05-20
SG11201500178QA (en)	2015-03-30

Publication	Publication Date	Title
AP4028A (en)	2017-02-04	New indolizine derivatives, method for preparing same and pharmaceutical compositions containing same
EP2927227A4 (en)	2015-12-30	ANTIBODY CONCENTRATOR REMEDY CONJUGATE, METHOD OF MANUFACTURING THEREOF, AND ANTIBODY TOGETHER THEREWITH
ZA201406233B (en)	2015-11-25	Pharmaceutical composition and administration thereof
ZA201503753B (en)	2016-08-31	Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
IL237839A0 (en)	2015-05-31	History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them
IL235414A (en)	2017-11-30	The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
AP2015008599A0 (en)	2015-07-31	Pharmaceutical composition for treating headache, and preparation method thereof
IL232577A0 (en)	2014-06-30	The history of morpholinylbenzotriazine, their preparation and pharmaceutical preparations containing them
EP2924042A4 (en)	2016-08-17	BIS-BETA-CARBOLINE COMPOUND AND METHOD OF MANUFACTURING, PHARMACEUTICAL COMPOSITION AND USE THEREOF
ZA201309559B (en)	2014-08-27	Comptothecin derivative, method for preparing same, pharmaceutical composition and use thereof
EP3020417A4 (en)	2017-01-18	Pharmaceutical composition for respiratory administration
EP3037099A4 (en)	2017-04-19	Pharmaceutical composition, preparation method therefor and use thereof
IL230219B (en)	2018-08-30	History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
IL239958A (en)	2017-11-30	A chewable oral preparation and process for preparing it
HUP1300033A2 (en)	2014-07-28	Improved process for producing pharmaceutical agent and intermediate
IL236562A0 (en)	2015-02-26	A pharmaceutical preparation with an improved flow capacity, a medical agent, and a method for its production and use
EP2752202A4 (en)	2015-04-15	PHARMACEUTICAL PREPARATION FOR MOLLE CAPSULES, COMPOSITION FOR PHARMACEUTICAL PREPARATION FOR MOLLE CAPSULES, AND PROCESS FOR PRODUCTION OF PHARMACEUTICAL PREPARATION FOR MOLLE CAPSULES
EP2665480A4 (en)	2014-08-06	PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING THEM
IL238826A (en)	2017-11-30	History of imidazole - piperidinyl, their preparation and their pharmaceutical preparations
GB2523481B (en)	2016-03-16	Composition for parental administration, method for producing and use thereof
HUP1100532A2 (en)	2013-04-29	Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
EP2979698A4 (en)	2016-11-16	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
SI2497774T1 (sl)	2014-02-28	Derivati dihidrooksazolobenzodiazepinona, postopki za njihovo pripravo in farmacevtski sestavki, ki te spojine vsebujejo
IL234614B (en)	2018-02-28	Pharmaceutical composition and preparation method thereof
IL236870A0 (en)	2015-03-31	The history of hydroxystatin, their preparation and pharmaceutical preparations containing them